GBLI vs MMC

For growth investors, Marsh & McLennan Companies, Inc.

(MMC) is the stronger pick with 7. 6% revenue growth year-over-year, versus 2. 0% for Global Indemnity Group, LLC (GBLI). Global Indemnity Group, LLC (GBLI) offers the better valuation at 15. 3x trailing P/E (9. 5x forward), making it the more compelling value choice. Analysts rate Marsh & McLennan Companies, Inc. (MMC) a "Hold" — based on 26 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Global Indemnity Group, LLC (GBLI) is the cheapest at 15.

3x versus Marsh & McLennan Companies, Inc. at 21. 3x. On forward P/E, Global Indemnity Group, LLC is actually cheaper at 9. 5x.

Over the past 5 years, Marsh & McLennan Companies, Inc.

(MMC) delivered a total return of +36. 6%, compared to +9. 7% for Global Indemnity Group, LLC (GBLI). Over 10 years, the gap is even starker: MMC returned +210. 8% versus GBLI's +17. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Marsh & McLennan Companies, Inc.

(MMC) is the lower-risk stock at 0. 14β versus Global Indemnity Group, LLC's 0. 14β — meaning GBLI is approximately 0% more volatile than MMC relative to the S&P 500. On balance sheet safety, Global Indemnity Group, LLC (GBLI) carries a lower debt/equity ratio of 1% versus 162% for Marsh & McLennan Companies, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Marsh & McLennan Companies, Inc.

(MMC) is pulling ahead at 7. 6% versus 2. 0% for Global Indemnity Group, LLC (GBLI). On earnings-per-share growth, the picture is similar: Marsh & McLennan Companies, Inc. grew EPS 8. 6% year-over-year, compared to -43. 9% for Global Indemnity Group, LLC. Over a 3-year CAGR, MMC leads at 7. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Marsh & McLennan Companies, Inc.

(MMC) is the more profitable company, earning 16. 6% net margin versus 5. 6% for Global Indemnity Group, LLC — meaning it keeps 16. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MMC leads at 23. 8% versus 7. 4% for GBLI. At the gross margin level — before operating expenses — GBLI leads at 49. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Global Indemnity Group, LLC (GBLI) trades at 9.

5x forward P/E versus 16. 9x for Marsh & McLennan Companies, Inc. — 7. 4x cheaper on a one-year earnings basis.

All stocks in this comparison pay dividends.

Global Indemnity Group, LLC (GBLI) offers the highest yield at 5. 2%, versus 1. 8% for Marsh & McLennan Companies, Inc. (MMC).

For long-horizon retirement investors, Marsh & McLennan Companies, Inc.

(MMC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 14), 1. 8% yield, +210. 8% 10Y return). Both have compounded well over 10 years (MMC: +210. 8%, GBLI: +17. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: GBLI is a small-cap deep-value stock; MMC is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.